Chile vs Costa Rica: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Chile
- Costa Rica
How they compare
Chile currently reports 1,483 Cases against 1,074 Cases in Costa Rica, a difference of 409 Cases.
That makes Chile's figure about 1.4 times Costa Rica's.
Across all 33 years both countries report, Chile has been ahead every year.
Chile ranks 6th and Costa Rica ranks 8th of 34 countries.
Chile has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Chile | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 444.86 Cases | 202.86 Cases | 242 Cases | Chile |
| 2000s | 568.7 Cases | 259.7 Cases | 309 Cases | Chile |
| 2010s | 1,072 Cases | 834.9 Cases | 237.1 Cases | Chile |
| 2020s | 1,674 Cases | 907.5 Cases | 766.5 Cases | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Chile or Costa Rica?
- Chile, at 1,483 Cases against 1,074 Cases in Costa Rica as of 2025.
- What is the difference in communicable diseases — communicable disease incidence between Chile and Costa Rica?
- 409 Cases, with Chile ahead.
- How many years of comparable data are there for Chile and Costa Rica?
- 33 years are reported by both, from 1993 to 2025.
- How do Chile and Costa Rica rank globally for communicable diseases — communicable disease incidence?
- Chile ranks 6th and Costa Rica ranks 8th of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.